
About Priska Pharma Private Limited
Data last updated:
Priska Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC276308. Its GSTIN is 10AAICP0722H1ZZ (Bihar). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Amod Kumar and Vikash Pandey.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No – 211 S/F Som Dutt Chamber II 9 Bhikaji Cama Place Near Hayat Hotel, New Delhi, Delhi, India – 110066.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.09 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹76.69 Lakh (net margin 36.6%) and EBITDA of ₹1.07 Cr (EBITDA margin 51%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 10% over five years.
The company is associated with 1 brand: Priska Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website priskapharma.com.
Company details
Contact details
Priska Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is priskapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No – 211 S/F Som Dutt Chamber II 9 Bhikaji Cama Place Near Hayat Hotel, New Delhi, Delhi, India – 110066
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Priska Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Priska Pharma operates one associated brand: Priska Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online provider of nutritional supplements and medicines for pregnant and lactating women in India. | priskapharma.com |
Business activity
The main business activity of Priska Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Priska Pharma Private Limited, buy the company report.
Financials of Priska Pharma Private Limited
FY 2025 filings availablePriska Pharma Private Limited reported revenue of ₹2.09 Cr (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 36% growth in the latest year. EBITDA rose 111% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.07 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹76.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 51% | ||||
| Net Profit Margin | 36.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Priska Pharma Private Limited, buy the company report.
Board of directors of Priska Pharma Private Limited
Priska Pharma has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amod Kumar | Director | 21 Jan 2023 | 3 Years 9 Months | Current |
| Vikash Pandey | Director | 21 Jan 2023 | 3 Years 9 Months | Current |
| Kundan Kumar Also directs: Priska Agrotech Private Limited, Priska Infosolutions Private Limited, Priska Buildcon Private Limited and 1 more | Additional Director | 31 Aug 2024 | 2 Years 2 Months | Current |
| Ajeet Kumar Also directs: Priska Agrotech Private Limited, Priska Infosolutions Private Limited, Priska Buildcon Private Limited and 1 more | Additional Director | 31 Aug 2024 | 2 Years 2 Months | Current |
| Manas Kumar Sircar | Additional Director | 25 Apr 2025 | 1 Years 6 Months | Current |
Auditor
Priska Pharma Private Limited is audited by RAJIV KUMAR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJIV KUMAR & CO. | FY 2023 | 018082C |
Shareholding
The shareholding of Priska Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Priska Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Priska Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Priska Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Priska Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAICP0722H1ZZ | Bihar | Active | 20 Jan 2018 |
| 10AAICP8522B1ZX | Bihar | Active | 07 Jan 2026 |
To see the full GST registrations and return filing status of Priska Pharma Private Limited, buy the company report.
Recent activity
Priska Pharma Private Limited has 8 board changes on record since 2020: 5 appointments and 3 cessations. The latest: Manas Kumar Sircar was appointed as Additional Director on 25 Apr 2025.
Frequently asked questions
Priska Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2015 (11+ years old) and is registered under CIN U24100DL2015PTC276308.
Priska Pharma has 5 current directors:
- Amod Kumar - Director
- Vikash Pandey - Director
- Kundan Kumar - Additional Director
- Ajeet Kumar - Additional Director
- Manas Kumar Sircar - Additional Director
The latest financial statements of Priska Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Priska Pharma is 10AAICP0722H1ZZ, registered in Bihar. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 10AAICP8522B1ZX (Bihar).
The CIN (Corporate Identification Number) of Priska Pharma is U24100DL2015PTC276308. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Priska Pharma was incorporated on 04 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Manas Kumar Sircar was appointed as Additional Director on 25 Apr 2025. Ajeet Kumar was appointed as Additional Director on 31 Aug 2024. Kundan Kumar was appointed as Additional Director on 31 Aug 2024. Priska Pharma has 8 board changes on record in total.
Priska Pharma can be reached through the website priskapharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Priska Pharma is at H.No – 211 SF Som Dutt Chamber II 9 Bhikaji Cama Place Near Hayat Hotel, New Delhi, Delhi, India – 110066.
Priska Pharma operates in the pharma industry, in the drug formulation and development segment.

